Hyperlipoproteinemia Type II [hyperlipoproteinemie typ II]

topical
460
Terms

autozomálně dominantní hypercholesterolemie
autozomálně dominantní hypercholesterolemie typu B
autozomálně dominantní hypercholesterolemie, typ B
esenciální hypercholesterolemie
familiární defekt apolipoproteinu B-100
familiární hypercholesterolemická xantomatóza
familiární hypercholesterolemie
familiární kombinovaná hypercholesterolemie
familiární kombinovaná hyperlipoproteinemie
hyperbetalipoproteinemie
hyperbetalipoproteinémie
hypercholesterolémie esenciální
hypercholesterolémie familiární
hyperlipoproteinémie typ II
hyperlipoproteinemie typ IIa
hyperlipoproteinémie typ IIa
hyperlipoproteinemie typ IIb
hyperlipoproteinémie typ IIb
porucha LDL receptorů

 

Apolipoprotein B-100, Familial Defective
Apolipoprotein B-100, Familial Ligand-Defective
Familial Combined Hyperlipoproteinemia
Hyper-beta-Lipoproteinemia
Hyper-Low Density Lipoproteinemia
Hyper-Low-Density-Lipoproteinemia
Hyperbetalipoproteinemia
Hypercholesterolemia, Autosomal Dominant
Hypercholesterolemia, Autosomal Dominant, Type B
Hypercholesterolemia, Essential
Hypercholesterolemia, Familial
Hypercholesterolemic Xanthomatosis, Familial
Hyperlipoproteinemia Type 2
Hyperlipoproteinemia Type IIa
Hyperlipoproteinemia Type IIb
Hyperlipoproteinemia, Type II
Hyperlipoproteinemia, Type IIa
LDL Receptor Disorder

Persistent link   https://www.medvik.cz/link/D006938
Definition

A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).

DUI
D006938 MeSH Browser
CUI
M0010819
Previous indexing
Hypercholesterolemia (1966-1979); Hyperlipidemia/familial & genetic (1966-1979)
History note
2007 (1980)
Public note
2007; see HYPERCHOLESTEROLEMIA, FAMILIAL 1980-2007

Allowable subheadings

BL
blood 44
CF
cerebrospinal fluid
CI
chemically induced
CL
classification 3
CO
complications 34
DI
diagnosis 158
DG
diagnostic imaging 3
DH
diet therapy 28
DT
drug therapy 181
EC
economics 2
EM
embryology
EN
enzymology 1
EP
epidemiology 42
EH
ethnology
ET
etiology 28
GE
genetics 128
HI
history 2
IM
immunology 1
ME
metabolism 14
MI
microbiology
MO
mortality 3
NU
nursing
PS
parasitology 1
PA
pathology 14
PP
physiopathology 18
PC
prevention & control 29
PX
psychology 3
RT
radiotherapy
RH
rehabilitation
SU
surgery
TH
therapy 102
UR
urine
VE
veterinary
VI
virology

C Diseases
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities 439
C16.320 Genetic Diseases, Inborn 1 219
C16.320.565 Metabolism, Inborn Errors 715
C16.320.565.398 Lipid Metabolism, Inborn Errors 154
C16.320.565.398.224 Barth Syndrome 6
C16.320.565.398.450 Hyperlipidemia, Familial Combined 68
C16.320.565.398.465 Hyperlipoproteinemia Type I 21
C16.320.565.398.481 Hyperlipoproteinemia Type II 460
C16.320.565.398.481.500 Homozygous Familial Hypercholesterolemia 6
C16.320.565.398.483 Hyperlipoproteinemia Type III 19
C16.320.565.398.487 Hyperlipoproteinemia Type IV 14
C16.320.565.398.493 Hyperlipoproteinemia Type V 6
C16.320.565.398.500 Hypolipoproteinemias 35
C16.320.565.398.641 Lipidoses 35
C16.320.565.398.745 Lipodystrophy, Congenital Generalized 2
C16.320.565.398.850 Smith-Lemli-Opitz Syndrome 30
C16.320.565.398.925 Xanthomatosis, Cerebrotendinous
C18 Nutritional and Metabolic Diseases 172
C18.452 Metabolic Diseases 1 205
C18.452.584 Lipid Metabolism Disorders 99
C18.452.584.500 Dyslipidemias 1 665
C18.452.584.500.500 Hyperlipidemias 1 240
C18.452.584.500.500.644 Hyperlipoproteinemias 771
C18.452.584.500.500.644.237 Hyperlipoproteinemia Type I 21
C18.452.584.500.500.644.475 Hyperlipoproteinemia Type II 460
C18.452.584.500.500.644.475.500 Homozygous Familial Hypercholesterolemia 6
C18.452.584.500.500.644.485 Hyperlipoproteinemia Type III 19
C18.452.584.500.500.644.490 Hyperlipoproteinemia Type IV 14
C18.452.584.500.500.644.495 Hyperlipoproteinemia Type V 6
C18.452.584.563 Lipid Metabolism, Inborn Errors 154
C18.452.584.563.224 Barth Syndrome 6
C18.452.584.563.450 Hyperlipidemia, Familial Combined 68
C18.452.584.563.465 Hyperlipoproteinemia Type I 21
C18.452.584.563.481 Hyperlipoproteinemia Type II 460
C18.452.584.563.481.500 Homozygous Familial Hypercholesterolemia 6
C18.452.584.563.483 Hyperlipoproteinemia Type III 19
C18.452.584.563.487 Hyperlipoproteinemia Type IV 14
C18.452.584.563.493 Hyperlipoproteinemia Type V 6
C18.452.584.563.497 Hypobetalipoproteinemia, Familial, Apolipoprotein B 1
C18.452.584.563.500 Hypolipoproteinemias 35
C18.452.584.563.641 Lipidoses 35
C18.452.584.563.745 Lipodystrophy, Congenital Generalized 2
C18.452.584.563.798 Lipodystrophy, Familial Partial 1
C18.452.584.563.824 Shwachman-Diamond Syndrome 2
C18.452.584.563.850 Smith-Lemli-Opitz Syndrome 30
C18.452.584.563.925 Xanthomatosis, Cerebrotendinous
C18.452.648 Metabolism, Inborn Errors 715
C18.452.648.398 Lipid Metabolism, Inborn Errors 154
C18.452.648.398.224 Barth Syndrome 6
C18.452.648.398.450 Hyperlipidemia, Familial Combined 68
C18.452.648.398.465 Hyperlipoproteinemia Type I 21
C18.452.648.398.481 Hyperlipoproteinemia Type II 460
C18.452.648.398.481.500 Homozygous Familial Hypercholesterolemia 6
C18.452.648.398.483 Hyperlipoproteinemia Type III 19
C18.452.648.398.487 Hyperlipoproteinemia Type IV 14
C18.452.648.398.493 Hyperlipoproteinemia Type V 6
C18.452.648.398.500 Hypolipoproteinemias 35
C18.452.648.398.641 Lipidoses 35
C18.452.648.398.745 Lipodystrophy, Congenital Generalized 2
C18.452.648.398.850 Smith-Lemli-Opitz Syndrome 30
C18.452.648.398.925 Xanthomatosis, Cerebrotendinous

Familial Hyperbeta- and Prebetalipoproteinemia Disease MeSH Browser

High serum cholesterol, familial Disease MeSH Browser

Hypercholesterolemia due to arg3500 mutation of Apo B-100 Disease MeSH Browser

Add

Narrower terms